AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States
- Details
- Category: AstraZeneca
Technion researchers have developed a new chemical process: Triazenolysis
- Details
- Category: Research
New drug targets for Alzheimer's identified from cerebrospinal fluid
- Details
- Category: Research
Using cerebrospinal fluid (CSF) collected from living patients, a team of researchers at Washington University School of Medicine in St. Louis has for the first time linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer's genesis and progression.
FDA approves first gene therapy for treatment of aromatic L-amino acid decarboxylase deficiency
- Details
- Category: FDA
New weight loss drug target burns energy and lowers appetite - without the nausea and vomiting
- Details
- Category: Research
Millions of people around the world benefit from weight loss drugs based on the incretin hormone GLP-1.
How immune cells "sniff out" pathogens
- Details
- Category: Research
New antibody could be promising cancer treatment
- Details
- Category: Research
Researchers have developed a unique type of antibody that both targets and delivers a drug package via the antibody itself, while simultaneously activating the immune system ("3-in-1 design") for personalised immunotherapy treatments.
Researchers make glioblastoma cells visible to attacking immune cells
- Details
- Category: Research
In a cell-based study, scientists at Washington University School of Medicine in St. Louis have forced glioblastoma cells to display immune system targets, potentially making them visible to immune cells and newly vulnerable to immunotherapies.
Scientists discover how specific E. coli bacteria drive colon cancer
- Details
- Category: Research
Bayer Foundation announces Science Awards winners of 2024
- Details
- Category: Bayer